Vitamin D and Estradiol supplementation may help prevent metabolic syndrome in post-menopausal women according to a new study.
Metabolic syndrome, which leads to abdominal obesity and heart disease in women may be prevented by supplementation with Vitamin D and Estradiol. Vitamin D and Estradiol are known for helping women improve bone health.
Once a woman becomes menopausal, her metabolism changes, and most women gain abdominal weight. A new study from China suggests that abdominal obesity, heart disease, and metabolic syndrome is directly related to estrogen loss in post-menopausal women.
Vitamin D has been associated with several markers of metabolic syndrome, including obesity, hyperglycemia, insulin resistance, and type 2 diabetes mellitus. It has also been demonstrated in a 20-year study that supplementation with vitamin d helps reduce the risk of metabolic syndrome.
The newest study from China was based on this understanding of the benefits of estrogen and vitamin D in post-menopausal women.
616 women between the ages of 49 and 86 were studied and it was found that there were improvements in those who took both estrogen and vitamin D. The vitamin D recipients had better lipid profiled, blood pressure as well as glucose levels. Estradiol had a negative effect showing higher cholesterol, triglycerides and blood pressure. Taken together, scientists now were beginning to understand that the two taken together had synergistic effects.
You can read more about this study below
Vitamin D And Estradiol Help Guard Against Heart Disease, Stroke, And Diabetes
Vitamin D and estrogen have already shown well-documented results in improving bone health in women. A new study from China suggests that this same combination could help prevent metabolic syndrome, a constellation of conditions that increases the risk of heart disease, stroke, and diabetes in postmenopausal women. Results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Metabolic syndrome has emerged as a major public health concern, affecting 30% to 60% of postmenopausal women worldwide. The progression of abdominal obesity and heart disease that lead to metabolic syndrome increases significantly as women age and appears to be directly associated with estrogen loss in postmenopausal women. This has led some researchers to recommend estradiol treatment for women who are fewer than 6 years postmenopausal as a means of preventing heart disease.